Page last updated: 2024-11-04

rofecoxib and Anemia, Sickle Cell

rofecoxib has been researched along with Anemia, Sickle Cell in 1 studies

Anemia, Sickle Cell: A disease characterized by chronic hemolytic anemia, episodic painful crises, and pathologic involvement of many organs. It is the clinical expression of homozygosity for hemoglobin S.

Research Excerpts

ExcerptRelevanceReference
"Rofecoxib is a selective cyclooxygenase-2 (COX-2) inhibitor approved for the treatment of pain and arthritis in adults."3.72Pharmacokinetics of rofecoxib in children with sickle cell hemoglobinopathy. ( Aranda, JV; Edwards, DJ; Frattarelli, DA; Haritos, D; Prescilla, RP, 2004)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Prescilla, RP1
Frattarelli, DA1
Haritos, D1
Aranda, JV1
Edwards, DJ1

Other Studies

1 other study available for rofecoxib and Anemia, Sickle Cell

ArticleYear
Pharmacokinetics of rofecoxib in children with sickle cell hemoglobinopathy.
    Journal of pediatric hematology/oncology, 2004, Volume: 26, Issue:10

    Topics: Administration, Oral; Adolescent; Analgesics, Non-Narcotic; Anemia, Sickle Cell; Anti-Inflammatory A

2004